Masao Hashimoto

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Magnetic Resonance

Combination Therapy

Endothelial Cells

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Science immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Amanda L Gill, Peter H Wang, Judong Lee, William H Hudson, Satomi Ando, Koichi Araki, Yinghong Hu, Andreas Wieland, Se Jin Im, Autumn Gavora, Christopher B Medina, Gordon J Freeman, Masao Hashimoto, Steven L Reiner, Rajesh M Valanparambil
PD-1 blockade increases the self-renewal of stem-like CD8 T cells to compensate for their accelerated differentiation into effectors. Science immunology 8 (86) (2023)
Laura Codarri Deak, Masao Hashimoto, Pablo Umaña, Christiane Neumann
Beyond checkpoint inhibition: PD-1 cis-targeting of an IL-2Rβγ-biased interleukin-2 variant as a novel approach to build on checkpoint inhibition. Oncoimmunology 12 (1) (2023)
Annapaola Mariniello, Tahseen H Nasti, Daniel Y Chang, Masao Hashimoto, Sakshi Malik, Daniel McManus, Judong Lee, Donald J McGuire, Maria Andrea Cardenas, Pablo Umaña, Valeria Nicolini, Morie A Gertz, Ananya Saha, Zachary S Buchwald, Haydn T Kissick, Ehsan Ghorani, Silvia Novello, Dario Sangiolo, Giorgio Vittorio Scagliotti, Suresh R Ramalingam, Rajesh M Valanparambil
Platinum-based chemotherapy attenuates the effector response of CD8 T cells to concomitant PD-1 blockade. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Masao Hashimoto, Koichi Araki, Maria Andrea Cardenas, Peng Li, Rohit R Jadhav, Haydn T Kissick, William H Hudson, Donald J McGuire, Rebecca C Obeng, Andreas Wieland, Judong Lee, Daniel T McManus, James L Ross, Se Jin Im, Junghwa Lee, Jian-Xin Lin, Bin Hu, Erin E West, Christopher D Scharer, Gordon J Freeman, Arlene H Sharpe, Suresh R Ramalingam, Alex Pellerin, Volker Teichgräber, William J Greenleaf, Christiane Neumann, Jorg J Goronzy, Pablo Umaña, Warren J Leonard, Kendall A Smith, Rajesh M Valanparambil
PD-1 combination therapy with IL-2 modifies CD8 + T cell exhaustion program. Nature 610 (7930) (2022)
Laura Codarri Deak, Valeria Nicolini, Masao Hashimoto, Maria Karagianni, Petra C Schwalie, Laura Lauener, Eleni Maria Varypataki, Marine Richard, Esther Bommer, Johannes Sam, Stefanie Joller, Mario Perro, Floriana Cremasco, Leo Kunz, Emilio Yanguez, Tamara Hüsser, Ramona Schlenker, Marisa Mariani, Vinko Tosevski, Sylvia Herter, Marina Bacac, Inja Waldhauer, Sara Colombetti, Xavier Gueripel, Stephan Wullschleger, Melanie Tichet, Douglas Hanahan, Haydn T Kissick, Stephane Leclair, Anne Freimoser-Grundschober, Stefan Seeber, Volker Teichgräber, Rajesh M Valanparambil, Christiane Neumann, Pablo Umaña
PD-1-cis IL-2R agonism yields better effectors from stem-like CD8 + T cells. Nature 610 (7930) (2022)